197 related articles for article (PubMed ID: 29212101)
1. Invitation letters increase participation in colorectal cancer screening - results from an observational study.
Zhan T; Hielscher T; Bilge A; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
Z Gastroenterol; 2017 Dec; 55(12):1307-1312. PubMed ID: 29212101
[No Abstract] [Full Text] [Related]
2. The effect of gender-specific invitation letters on utilization of colorectal cancer screening.
Zhan T; Hielscher T; Eckardt M; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
Z Gastroenterol; 2019 Sep; 57(9):1051-1058. PubMed ID: 31525797
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Differing Invitation Models on the Uptake of Immunological Fecal Occult Blood Testing.
Gruner LF; Hoffmeister M; Ludwig L; Meny S; Brenner H
Dtsch Arztebl Int; 2020 Jun; 117(25):423-430. PubMed ID: 32885780
[TBL] [Abstract][Full Text] [Related]
4. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
[TBL] [Abstract][Full Text] [Related]
5. Screening for Bowel Cancer: Increasing Participation via Personal Invitation.
Hoffmeister M; Holleczek B; Zwink N; Stock C; Stegmaier C; Brenner H
Dtsch Arztebl Int; 2017 Feb; 114(6):87-93. PubMed ID: 28266301
[TBL] [Abstract][Full Text] [Related]
6. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
7. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.
Stoffel S; Benito L; Milà N; Travier N; Binefa G; Vidal C; Espinosa J; Moreno V; Garcia M
Prev Med; 2019 Feb; 119():58-62. PubMed ID: 30594532
[TBL] [Abstract][Full Text] [Related]
8. Reinvitation to screening colonoscopy: a randomized-controlled trial of reminding letter and invitation to educational meeting on attendance in nonresponders to initial invitation to screening colonoscopy (REINVITE).
Pisera M; Kaminski MF; Kraszewska E; Rupinski M; Regula J
Eur J Gastroenterol Hepatol; 2016 May; 28(5):538-42. PubMed ID: 26967693
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
Stock C; Ihle P; Schubert I; Brenner H
Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
[TBL] [Abstract][Full Text] [Related]
10. Two randomized controlled trials for colorectal cancer screening invitations developed using a behavioral science approach.
Tinmouth J; Llovet D; Sutradhar R; Tsiplova K; Roushani J; Lee A; Hader J; Rabeneck L; Paszat L
Prev Med; 2022 Feb; 155():106918. PubMed ID: 34953810
[TBL] [Abstract][Full Text] [Related]
11. An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care.
Goldshore MA; Mehta SJ; Fletcher W; Tzanis G; Doubeni CA; Paulson EC
Am J Prev Med; 2020 Jul; 59(1):41-48. PubMed ID: 32564804
[TBL] [Abstract][Full Text] [Related]
12. Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.
Hamashima C; Sano H
BMC Cancer; 2018 Mar; 18(1):345. PubMed ID: 29587681
[TBL] [Abstract][Full Text] [Related]
13. Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe.
Toes-Zoutendijk E; Portillo I; Hoeck S; de Brabander I; Perrin P; Dubois C; van Leerdam M; Lansdorp-Vogelaar I; Bardou M
J Med Screen; 2020 Jun; 27(2):68-76. PubMed ID: 31645173
[TBL] [Abstract][Full Text] [Related]
14. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
15. Effect of Various Invitation Schemes on the Use of Fecal Immunochemical Tests for Colorectal Cancer Screening: Protocol for a Randomized Controlled Trial.
Gruner LF; Hoffmeister M; Ludwig L; Brenner H
JMIR Res Protoc; 2020 Apr; 9(4):e16413. PubMed ID: 32242518
[TBL] [Abstract][Full Text] [Related]
16. An advance notification letter increases participation in colorectal cancer screening.
Cole SR; Smith A; Wilson C; Turnbull D; Esterman A; Young GP
J Med Screen; 2007; 14(2):73-5. PubMed ID: 17626705
[TBL] [Abstract][Full Text] [Related]
17. Determinants of colorectal cancer screening in Germany: a claims data analysis.
Pardey N; Kreis K; Schmidt T; Stahmeyer JT; Krauth C; Zeidler J
Z Gastroenterol; 2021 Jul; 59(7):644-656. PubMed ID: 34171930
[TBL] [Abstract][Full Text] [Related]
18. Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.
Bauer A; Riemann JF; Seufferlein T; Reinshagen M; Hollerbach S; Haug U; Unverzagt S; Boese S; Ritter-Herschbach M; Jahn P; Frese T; Harris M; Landenberger M
Dtsch Arztebl Int; 2018 Oct; 115(43):715-722. PubMed ID: 30518470
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening.
Suchánek Š; Grega T; Zavoral M
Vnitr Lek; 2018; 64(6):679-683. PubMed ID: 30223667
[TBL] [Abstract][Full Text] [Related]
20. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
